Search Results | Cancer Research | American Association for Cancer Research

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Intestinal Epithelial HuR Modulates Distinct Pathways of Proliferation and Apoptosis and Attenuates Small Intestinal and Colonic Tumor Development

Antonina Giammanco, Valerie Blanc, Grace Montenegro, Coen Klos, Yan Xie, Susan Kennedy, Jianyang Luo, Sung-Hee Chang, Timothy Hla, ILKe Nalbantoglu, Sekhar Dharmarajan, Nicholas O. Davidson

Cancer Res (2014) 74 (18): 5322–5335.

DOI: https://doi.org/10.1158/0008-5472.CAN-14-0726

Published: 14 September 2014

View article

Includes: Supplementary data

Journal Articles

VEGF-A Induces Angiogenesis by Perturbing the Cathepsin-Cysteine Protease Inhibitor Balance in Venules, Causing Basement Membrane Degradation and Mother Vessel Formation

Sung-Hee Chang, Keizo Kanasaki, Vasilena Gocheva, Galia Blum, Jay Harper, Marsha A. Moses, Shou-Ching Shih, Janice A. Nagy, Johanna Joyce, Matthew Bogyo, Raghu Kalluri, Harold F. Dvorak

Cancer Res (2009) 69 (10): 4537–4544.

DOI: https://doi.org/10.1158/0008-5472.CAN-08-4539

Published: 15 May 2009

View article

Journal Articles

HER2/neu-Induced Mammary Tumorigenesis and Angiogenesis Are Reduced in Cyclooxygenase-2 Knockout Mice

Louise R. Howe, Sung-Hee Chang, Kelly C. Tolle, Rachelle Dillon, Lawrence J.T. Young, Robert D. Cardiff, Robert A. Newman, Peiying Yang, Howard T. Thaler, William J. Muller, Clifford Hudis, Anthony M.C. Brown, Timothy Hla, Kotha Subbaramaiah, Andrew J. Dannenberg

Cancer Res (2005) 65 (21): 10113–10119.

DOI: https://doi.org/10.1158/0008-5472.CAN-05-1524

Published: 01 November 2005

View article

Journal Articles

The Prostaglandin E₂ Receptor EP2 Is Required for Cyclooxygenase 2–Mediated Mammary Hyperplasia

Sung-Hee Chang, Youxi Ai, Richard M. Breyer, Timothy F. Lane, Timothy Hla

Cancer Res (2005) 65 (11): 4496–4499.

DOI: https://doi.org/10.1158/0008-5472.CAN-05-0129

Published: 01 June 2005

View article

Journal Articles

Cytoplasmic HuR Expression Is a Prognostic Factor in Invasive Ductal Breast Carcinoma

Mira Heinonen, Petri Bono, Kirsi Narko, Sung-Hee Chang, Johan Lundin, Heikki Joensuu, Henry Furneaux, Timothy Hla, Caj Haglund, Ari Ristimäki

Cancer Res (2005) 65 (6): 2157–2161.

DOI: https://doi.org/10.1158/0008-5472.CAN-04-3765

Published: 21 March 2005

View article

NARROW

Intestinal Epithelial HuR Modulates Distinct Pathways of Proliferation and Apoptosis and Attenuates Small Intestinal and Colonic Tumor Development

VEGF-A Induces Angiogenesis by Perturbing the Cathepsin-Cysteine Protease Inhibitor Balance in Venules, Causing Basement Membrane Degradation and Mother Vessel Formation

HER2/neu-Induced Mammary Tumorigenesis and Angiogenesis Are Reduced in Cyclooxygenase-2 Knockout Mice

The Prostaglandin E₂ Receptor EP2 Is Required for Cyclooxygenase 2–Mediated Mammary Hyperplasia

Cytoplasmic HuR Expression Is a Prognostic Factor in Invasive Ductal Breast Carcinoma

Email alerts

AACR Journals

Intestinal Epithelial HuR Modulates Distinct Pathways of Proliferation and Apoptosis and Attenuates Small Intestinal and Colonic Tumor Development

VEGF-A Induces Angiogenesis by Perturbing the Cathepsin-Cysteine Protease Inhibitor Balance in Venules, Causing Basement Membrane Degradation and Mother Vessel Formation

HER2/neu-Induced Mammary Tumorigenesis and Angiogenesis Are Reduced in Cyclooxygenase-2 Knockout Mice

The Prostaglandin E2 Receptor EP2 Is Required for Cyclooxygenase 2–Mediated Mammary Hyperplasia

Cytoplasmic HuR Expression Is a Prognostic Factor in Invasive Ductal Breast Carcinoma

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only

The Prostaglandin E₂ Receptor EP2 Is Required for Cyclooxygenase 2–Mediated Mammary Hyperplasia